← Eichor
Condition: Cellulitis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cellulitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial
Phase 4 · 1 location(s) · Frieder Schaumburg · NCT05899140
Transoral Ultrasound Versus no Transoral Ultrasound in Diagnostic Workup of Peritonsillar Abscess
NA · 3 location(s) · Rigshospitalet, Denmark · NCT07577232
Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
Phase N/A · 1 location(s) · University Medical Center Groningen · NCT04615065
Perspectives on Antibiotics and Tracking Symptoms in Children
NA · 1 location(s) · Murdoch Childrens Research Institute · NCT07093749
Cellulitis Optimal Antibiotic Treatment
Phase 3 · 1 location(s) · University of Southampton · NCT05584007
Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections
Phase 4 · 1 location(s) · Indiana University · NCT06982105
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Ca
Phase N/A · 51 location(s) · Duke University · NCT04278404
Intravenous Versus Oral Treatment of the Main Acute Infections
NA · 7 location(s) · University of Southern Denmark · NCT06715306
Complicated Infections in Otorhinolaryngology
Phase N/A · 1 location(s) · University Medical Centre Ljubljana · NCT06023550
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.